Multifunctional nanocarrier-based
theranostics is supposed to overcome some key problems in
cancer treatment. In this work, a novel method for the preparation of a fluorescent mesoporous
silica-
carbon dot nanohybrid was developed.
Carbon dots (CDs), from
folic acid as the raw material, were prepared in situ and anchored on the surface of amino-modified mesoporous
silica nanoparticles (MSNs-NH2) via a microwave-assisted solvothermal reaction. The as-prepared nanohybrid (designated MSNs-CDs) not only exhibited strong and stable yellow emission but also preserved the unique features of MSNs (e.g., mesoporous structure, large specific surface area, and good biocompatibility), demonstrating a potential capability for fluorescence imaging-guided drug delivery. More interestingly, the MSNs-CDs nanohybrid was able to selectively target
folate receptor-overexpressing
cancer cells (e.g., HeLa), indicating that
folic acid still retained its function even after undergoing the solvothermal reaction. Benefited by these excellent properties, the fluorescent MSNs-CDs nanohybrid can be employed as a fluorescence-guided nanocarrier for the targeted delivery of anticancer drugs (e.g.,
doxorubicin), thereby enhancing chemotherapeutic efficacy and reducing side effects. Our studies may provide a facile strategy for the fabrication of multifunctional MSN-based
theranostic platforms, which is beneficial in the diagnosis and
therapy of
cancers in future.